FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

1209111000001101: Mesalazine 500mg suppositories 10 suppository (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22587501000001111 Mesalazine 500mg suppositories 10 suppository (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22587601000001110 Mesalazine 500mg suppositories 10 suppository en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mesalazine 500mg suppositories 10 suppository Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 10 suppository Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 10 suppository Is pack of Product containing precisely mesalazine 500 milligram/1 each conventional release rectal suppository false Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 10 suppository Has active ingredient Mesalazine false Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 10 suppository VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 10 suppository VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 10 suppository Has manufactured dose form Suppository false Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 10 suppository Has VMP Product containing precisely mesalazine 500 milligram/1 each conventional release rectal suppository true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 10 suppository Has specific active ingredient Mesalazine true Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories 10 suppository Has dispensed dose form Suppository true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Asacol 500mg suppositories (Procter & Gamble Pharmaceuticals UK Ltd) 10 suppository Is a True Mesalazine 500mg suppositories 10 suppository Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories (Ennogen Healthcare Ltd) 10 suppository Is a False Mesalazine 500mg suppositories 10 suppository Inferred relationship Existential restriction modifier
Mesalazine 500mg suppositories (J M McGill Ltd) 10 suppository Is a False Mesalazine 500mg suppositories 10 suppository Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start